Background Incomplete adherence to tuberculosis (TB) treatment increases the risk of
delayed culture conversion with continued transmission in the community, as well as …

The telemedicine intervention in chronic disease management promises to involve patients
in their own care, provides continuous monitoring by their healthcare providers, identifies …

The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …

Executive summary Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …

In order to support countries in their effort to respond to the challenges posed by the TB
epidemic over the years, WHO has produced and regularly updated guidelines for the …

Background Directly observed treatment (DOT) has been the standard of care for
tuberculosis since the early 1990s, but it is inconvenient for patients and service providers …

Poor medication adherence may increase rates of loss to follow-up, disease relapse and
drug resistance for individuals with active tuberculosis (TB). While TB programmes have …

Digital technologies are increasingly harnessed to support treatment of persons with
tuberculosis (TB). Since in-person directly observed treatment (DOT) can be resource …

SETTING: Directly observed therapy (DOT), the standard of care for monitoring patients on
treatment for tuberculosis (TB), requires substantial health department resources, and can …

Background The development of drug-resistant (DR) tuberculosis (TB) has become an
increasing concern over the past few decades as the result of numerous factors, including …